JH

James Hardiman

General Partner at DCVC - focused on early stage, applied AI & deep tech investments

San Francisco, California

Invests in

  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $25,000,000.00
  • Target Investment:

    $15,000,000.00

Work Experience

2023

  • Investor and Board Observer

    2023

    Clean Ammonia on Demand

  • General Partner

    2013

    With more than $4B AUM, DCVC backs entrepreneurs solving trillion-dollar problems to multiply the benefits of capitalism for everyone while reducing its costs.

  • Investor and Board Observer

    2017

    Decoding biology to radically improve lives Board Observer 2017 to 2020

2023

  • Investor and Board Director

    2023

    AI diagnostics to interpret solid tumors, so physicians and patients can make evidence-based decisions about cancer treatments

2022

  • Investor and Board Director

    2022

    An AI-native biotechnology company harnessing self-supervised learning and human multimodal data for better precision immunotherapies.

  • Investor and Board Director

    2021

    Developing single cell platforms to unlock a key bottleneck in immunotherapy, enabling curative treatments.

2020

  • Investor and Board Director

    2020

    The world's first accessible X-Ray CT scanner for engineers

  • Investor and Board Director

    2020

    Transforming how software is built and shipped.

  • Investor and Board Director

    2020

  • Investor and Board Director

    2017

    Engineering software for advanced manufacturing